Clinical trialNCT07049055RecruitingPhase 1/PHASE2Interventional

A Clinical Trial to Evaluate EDV Nanocell Therapy With Gemcitabine and Nab-paclitaxel in Pancreatic Cancer

SponsorEngeneic Pty LimitedEnrollment144PDAC - Pancreatic Ductal AdenocarcinomaPancreatic Cancer, Metastatic

View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Dr Himanshu Brahmbhatt, Ph.D
Engeneic Pty Limited
Study Director
clinicaltrials.gov ↗
Dr Jennifer MacDiarmid, Ph.D
Engeneic Pty Limited
Study Director
clinicaltrials.gov ↗
Dr Linda Y.Wu, MD
Columbia University Medical Center/ Herbert Irving Pavilion
Principal Investigator
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

4 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

Chan Soon-Shiong Institute for Medicine
El Segundo, California, United States
Active, not recruiting
Atlantic Health
Summit, New Jersey, United States
Usman Shah, MD
Recruiting
Columbia University Irving Medical Center
New York, New York, United States
Dr Linda Y.Wu, MD
Recruiting
Taylor Cancer Center
Maumee, Ohio, United States
Dr John Nemunaitis, MD
Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 12 Jan 2026
Primary completion: 30 Sept 2028
Completion: 30 Sept 2028
Last update posted: 27 Feb 2026
Registered enrollment: 144
Registry id: NCT07049055

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.